FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Center for Computational Systems Medicine
leaf

FusionGeneSummary

leaf

FusionProtFeature

leaf

FusionGeneSequence

leaf

FusionGenePPI

leaf

RelatedDrugs

leaf

RelatedDiseases

Fusion gene ID: 23102

FusionGeneSummary for MYO18A_IGF2

check button Fusion gene summary
Fusion gene informationFusion gene name: MYO18A_IGF2
Fusion gene ID: 23102
HgeneTgene
Gene symbol

MYO18A

IGF2

Gene ID

399687

3481

Gene namemyosin XVIIIAinsulin like growth factor 2
SynonymsMAJN|MYSPDZ|SP-R210|SPR210C11orf43|GRDF|IGF-II|PP9974
Cytomap

17q11.2

11p15.5

Type of geneprotein-codingprotein-coding
Descriptionunconventional myosin-XVIIIaSP-A receptor subunit SP-R210 alphaSmolecule associated with JAK3 N-terminusmyosin 18Amyosin containing PDZ domainmyosin containing a PDZ domainsurfactant protein receptor SP-R210insulin-like growth factor IIT3M-11-derived growth factorinsulin-like growth factor 2 (somatomedin A)insulin-like growth factor type 2preptin
Modification date2018051920180527
UniProtAcc

Q92614

P01344

Ensembl transtripts involved in fusion geneENST00000354329, ENST00000529578, 
ENST00000533112, ENST00000531253, 
ENST00000527372, 
ENST00000381395, 
ENST00000381406, ENST00000416167, 
ENST00000300632, ENST00000434045, 
ENST00000381392, ENST00000381389, 
ENST00000418738, 
Fusion gene scores* DoF score18 X 14 X 9=226823 X 24 X 8=4416
# samples 2120
** MAII scorelog2(21/2268*10)=-3.43295940727611
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(20/4416*10)=-4.46466826700344
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: MYO18A [Title/Abstract] AND IGF2 [Title/Abstract] AND fusion [Title/Abstract]

Functional or gene categories assigned by FusionGDB annotation
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneIGF2

GO:0008284

positive regulation of cell proliferation

28873464

TgeneIGF2

GO:0042104

positive regulation of activated T cell proliferation

15694994

TgeneIGF2

GO:0043410

positive regulation of MAPK cascade

11500939

TgeneIGF2

GO:0045840

positive regulation of mitotic nuclear division

11500939

TgeneIGF2

GO:0046628

positive regulation of insulin receptor signaling pathway

11500939

TgeneIGF2

GO:0051897

positive regulation of protein kinase B signaling

11500939


check button Fusion gene information from three resources
(ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018))
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
Data typeSourceCancer typeSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
TCGARVKIRCTCGA-B8-A54K-01AMYO18Achr17

27421031

-IGF2chr11

2170575

-
* LD: Li Ding group's fusion gene list
  RV: Roel Verhaak group's fusion gene list
  ChiTaRs fusion database

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
intron-intronENST00000354329ENST00000381395MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000354329ENST00000381406MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000354329ENST00000416167MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-5UTRENST00000354329ENST00000300632MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000354329ENST00000434045MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000354329ENST00000381392MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000354329ENST00000381389MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000354329ENST00000418738MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000529578ENST00000381395MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000529578ENST00000381406MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000529578ENST00000416167MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-5UTRENST00000529578ENST00000300632MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000529578ENST00000434045MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000529578ENST00000381392MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000529578ENST00000381389MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000529578ENST00000418738MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000533112ENST00000381395MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000533112ENST00000381406MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000533112ENST00000416167MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-5UTRENST00000533112ENST00000300632MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000533112ENST00000434045MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000533112ENST00000381392MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000533112ENST00000381389MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000533112ENST00000418738MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000531253ENST00000381395MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000531253ENST00000381406MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000531253ENST00000416167MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-5UTRENST00000531253ENST00000300632MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000531253ENST00000434045MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000531253ENST00000381392MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000531253ENST00000381389MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000531253ENST00000418738MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000527372ENST00000381395MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000527372ENST00000381406MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000527372ENST00000416167MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-5UTRENST00000527372ENST00000300632MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000527372ENST00000434045MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000527372ENST00000381392MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000527372ENST00000381389MYO18Achr17

27421031

-IGF2chr11

2170575

-
intron-intronENST00000527372ENST00000418738MYO18Achr17

27421031

-IGF2chr11

2170575

-

Top

FusionProtFeatures for MYO18A_IGF2


check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
MYO18A

Q92614

IGF2

P01344

May link Golgi membranes to the cytoskeleton andparticipate in the tensile force required for vesicle budding fromthe Golgi. Thereby, may play a role in Golgi membrane traffickingand could indirectly give its flattened shape to the Golgiapparatus (PubMed:19837035, PubMed:23345592). Alternatively, inconcert with LURAP1 and CDC42BPA/CDC42BPB, has been involved inmodulating lamellar actomyosin retrograde flow that is crucial tocell protrusion and migration (PubMed:18854160). May be involvedin the maintenance of the stromal cell architectures required forcell to cell contact (By similarity). Regulates trafficking,expression, and activation of innate immune receptors onmacrophages. Plays a role to suppress inflammatory responsivenessof macrophages via a mechanism that modulates CD14 trafficking(PubMed:25965346). Acts as a receptor of surfactant-associatedprotein A (SFTPA1/SP-A) and plays an important role ininternalization and clearance of SFTPA1-opsonized S.aureus byalveolar macrophages (PubMed:16087679, PubMed:21123169). Stronglyenhances natural killer cell cytotoxicity (PubMed:27467939).{ECO:0000250|UniProtKB:Q9JMH9, ECO:0000269|PubMed:16087679,ECO:0000269|PubMed:18854160, ECO:0000269|PubMed:19837035,ECO:0000269|PubMed:21123169, ECO:0000269|PubMed:23345592,ECO:0000269|PubMed:25965346, ECO:0000269|PubMed:27467939}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page

.

* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

FusionGeneSequence for MYO18A_IGF2


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences.
(nt: nucleotides, aa: amino acids)

* Fusion amino acid sequences.

* Fusion transcript sequences (only coding sequence (CDS) region).

* Fusion transcript sequences (Full-length transcript).

Top

FusionGenePPI for MYO18A_IGF2


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page

.

check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors
MYO18AGRB2, ARAF, MARK4, CUL4B, ATXN1, PAN2, ENO1, SHMT2, MOV10, NXF1, YIF1B, DDRGK1, LIMS1, LRFN4, PYCR2, UPK3B, RCN1, SEPT1, SP6, CDKL4, FIG4, SLC30A6, SPC25, UQCRB, YEATS4, DDX46, DIEXF, PUF60, SMARCA4, ACTA1, ACTB, ACTG1, ACTN4, AP2A1, ANXA2, DST, CALM1, CAPZA1, CAPZA2, CAPZB, CFL1, CFL2, AP2M1, CLTA, CLTB, CLTC, CSNK1A1, DAB2, DAPK3, DBN1, DSG2, CTTN, FLII, FLNA, FLNB, FYN, GSN, HMGB2, ABLIM1, LMO7, MYO1B, MYH9, MYL6, MYO1C, MYO1E, MYO5A, MYO5B, MYO6, PPP1R12A, PPP1R12B, PIK3C2A, PLEC, PPP1CA, PPP1CB, TWF1, RANGAP1, SPTAN1, SPTBN1, SPTBN2, SSFA2, ST5, SVIL, TMOD1, TNFAIP1, TPM1, TPM2, TPM3, TPM4, CORO2A, LUZP1, PICALM, SORBS2, LRRFIP2, TJP2, CDC42BPB, CLINT1, ARHGAP11A, ARHGEF17, SEC16A, WDR1, ARPC4, ARPC3, ARPC1B, ACTR3, ACTR2, BASP1, DCTN2, MYL12A, DSTN, TRIOBP, AKAP2, SYNPO, CEP162, LIMCH1, SIPA1L3, MPRIP, COBL, SPECC1L, FBXO46, CORO1C, CCRN4L, PLEKHG3, RAI14, TES, TMOD3, LIMA1, BMP2K, MYO5C, CORO1B, KIAA1211, CGN, MICAL3, ARHGAP21, AFAP1, INF2, EFHD2, CYBRD1, MYO19, ARPC5L, KCTD10, LZTS2, STON2, SSH2, PHLDB2, NEXN, SPECC1, MISP, MYL6B, PPP1R18, TPRN, DDX51, CDK2, IQGAP1, PLK2, ANLN, GAN, MYL3, RPL15, PATL1, HBZ, NOX4, DLSTIGF2NOV, IGFBP7, IGFBP1, TF, IGFBP3, VTN, IDE, IGFBP6, IGFBP4, IGFBP5, BAG6, NMRK2, FAF1, PCSK4, RBPMS


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

RelatedDrugs for MYO18A_IGF2


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.0 2018-04-02)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status

Top

RelatedDiseases for MYO18A_IGF2


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
TgeneIGF2C0004903Beckwith-Wiedemann Syndrome2CTD_human
TgeneIGF2C0015934Fetal Growth Retardation2CTD_human;HPO
TgeneIGF2C0036341Schizophrenia2PSYGENET
TgeneIGF2C0206686Adrenocortical carcinoma2CTD_human;HPO
TgeneIGF2C2239176Liver carcinoma2CTD_human;HPO
TgeneIGF2C0000786Spontaneous abortion1CTD_human
TgeneIGF2C0002395Alzheimer's Disease1CTD_human
TgeneIGF2C0002871Anemia1CTD_human
TgeneIGF2C0004153Atherosclerosis1CTD_human
TgeneIGF2C0004352Autistic Disorder1CTD_human
TgeneIGF2C0005941Bone Diseases, Developmental1CTD_human
TgeneIGF2C0009241Cognition Disorders1CTD_human
TgeneIGF2C0009375Colonic Neoplasms1CTD_human
TgeneIGF2C0009404Colorectal Neoplasms1CTD_human
TgeneIGF2C0018273Growth Disorders1CTD_human
TgeneIGF2C0019284Diaphragmatic Hernia1CTD_human
TgeneIGF2C0020224Polyhydramnios1CTD_human
TgeneIGF2C0020615Hypoglycemia1CTD_human
TgeneIGF2C0023903Liver neoplasms1CTD_human
TgeneIGF2C0025261Memory Disorders1CTD_human
TgeneIGF2C0027708Nephroblastoma1CTD_human;HPO
TgeneIGF2C0027746Nerve Degeneration1CTD_human
TgeneIGF2C0028754Obesity1CTD_human
TgeneIGF2C0030567Parkinson Disease1CTD_human
TgeneIGF2C0032045Placenta Disorders1CTD_human
TgeneIGF2C0032927Precancerous Conditions1CTD_human
TgeneIGF2C0035412Rhabdomyosarcoma1CTD_human
TgeneIGF2C0175693Russell-Silver syndrome1CTD_human
TgeneIGF2C0206624Hepatoblastoma1CTD_human;HPO
TgeneIGF2C0678807prenatal alcohol exposure1PSYGENET
TgeneIGF2C0752347Lewy Body Disease1CTD_human